We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+1.25%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$5.72M
Cap. Flow
+$3.93M
Cap. Flow %
1.46%
Top 10 Hldgs %
30.56%
Holding
77
New
2
Increased
36
Reduced
30
Closed
2

Top Buys

Rank Stock Value
1
CLB icon
Core Laboratories
CLB
+$2.14M
2
KDP icon
Keurig Dr Pepper
KDP
+$1.04M
3
DLX icon
Deluxe
DLX
+$873K
4
GPN icon
Global Payments
GPN
+$562K
5
TJX icon
TJX Companies
TJX
+$438K

Top Sells

Rank Stock Value
1
OXY icon
Occidental Petroleum
OXY
+$2.03M
2
BBBY
Bed Bath & Beyond Inc
BBBY
+$793K
3
UNH icon
UnitedHealth
UNH
+$734K
4
GILD icon
Gilead Sciences
GILD
+$669K
5
ABT icon
Abbott
ABT
+$574K

Sector Composition

Rank Sector Weight
1 Technology 19%
2 Consumer Discretionary 16.49%
3 Healthcare 16.44%
4 Industrials 13.77%
5 Consumer Staples 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EV
26
DELISTED
Eaton Vance Corp.
EV
$4.67M 1.74%
122,443
+2,145
+2% +$82.7K
AMGN icon
27
Amgen
AMGN
$196B
$4.44M 1.66%
36,031
+2,017
+6% +$245K
CBRL icon
28
Cracker Barrel
CBRL
$1.18B
$4.39M 1.64%
45,152
+3,897
+9% +$393K
CPRT icon
29
Copart
CPRT
$25.4B
$4.18M 1.56%
919,296
-1,600
-0.2% -$7.1K
K
30
DELISTED
Kellanova
K
$4.04M 1.51%
68,625
+1,429
+2% +$81.1K
ALTR
31
DELISTED
Altera Corp
ALTR
$4.02M 1.5%
111,013
-3,146
-3% -$108K
NVO
32
Novo Nordisk
NVO
$220B
$3.94M 1.47%
172,712
+4,962
+3% +$106K
ABBV icon
33
AbbVie
ABBV
$447B
$3.6M 1.34%
70,128
– –
COL
34
DELISTED
Rockwell Collins
COL
$3.54M 1.32%
44,449
-866
-2% -$68.1K
DLTR icon
35
Dollar Tree
DLTR
$24.2B
$3.17M 1.18%
60,817
+3,180
+6% +$169K
TPR icon
36
Tapestry
TPR
$28.4B
$3.09M 1.15%
62,192
-61
-0.1% -$3.04K
CLB icon
37
Core Laboratories
CLB
$518M
$2.89M 1.08%
14,547
+11,313
+350% +$2.14M
PDCO
38
DELISTED
Patterson Companies, Inc.
PDCO
$2.88M 1.07%
68,944
-70
-0.1% -$2.86K
XOM icon
39
ExxonMobil
XOM
$615B
$2.75M 1.03%
28,188
-124
-0.4% -$11.8K
DHR icon
40
Danaher
DHR
$143B
$2.74M 1.02%
54,281
-186
-0.3% -$9.47K
EXPD icon
41
Expeditors International
EXPD
$23.3B
$2.68M 1%
67,739
-100
-0.1% -$4.1K
KMB icon
42
Kimberly-Clark
KMB
$36B
$2.58M 0.96%
24,458
+698
+3% +$72.3K
IBM icon
43
IBM
IBM
$200B
$2.56M 0.95%
13,906
-82
-0.6% -$14.4K
CNI icon
44
Canadian National Railway
CNI
$77.1B
$2.38M 0.89%
42,385
+4,644
+12% +$256K
ABT icon
45
Abbott
ABT
$177B
$2.29M 0.86%
59,593
-14,885
-20% -$574K
LH icon
46
Labcorp
LH
$22.9B
$2.18M 0.81%
25,858
+1,164
+5% +$92.8K
CSCO icon
47
Cisco
CSCO
$439B
$2.16M 0.81%
96,496
-2,198
-2% -$48.6K
LLY icon
48
Eli Lilly
LLY
$1.03T
$1.89M 0.7%
32,109
– –
DLX icon
49
Deluxe
DLX
$1.2B
$1.85M 0.69%
35,202
+17,364
+97% +$873K
OXY icon
50
Occidental Petroleum
OXY
$54.9B
$1.76M 0.65%
19,236
-22,733
-54% -$2.03M
1
2
3 4

Similar funds

AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
FCM
Fourpath Capital Management Oklahoma City, Oklahoma $697M AUM 29.98% 1-Year Est. Return
GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JLB & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, JLB & Associates held 77 positions worth $268M, up 2.2% from $263M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

JLB & Associates's Q1 2014 filing shows 2 new, 36 increased, 30 reduced and 2 closed positions. Its largest new stake was Keurig Dr Pepper: 20,566 shares worth $1.12M. The largest sale was Occidental Petroleum, an estimated $2.03M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • JLB & Associates's largest Q1 2014 buy was Keurig Dr Pepper: 20,566 shares worth $1.12M.
  • JLB & Associates added most to Core Laboratories in Q1 2014, an estimated $2.14M increase.
  • JLB & Associates's biggest Q1 2014 reduction was Occidental Petroleum, cutting an estimated $2.03M.
  • JLB & Associates fully exited Bed Bath & Beyond Inc in Q1 2014, selling an estimated $793K.
  • JLB & Associates's ten largest holdings make up 31% of its $268M portfolio in Q1 2014.
  • JLB & Associates opened 2 new positions and closed 2 in Q1 2014.
  • JLB & Associates's portfolio value rose 2.2% quarter-over-quarter to $268M.

Based on JLB & Associates's 13F filing for Q1 2014, filed 4 Apr 2014.